Biotics Research

Porphyra-Zyme

F
N+ Score58
Vitamins & MineralsServing: 1 Tablet(s)Type: Botanical with Nutrients

Biotics Research Porphyra-Zyme is classified as a 'Botanical with Nutrients' supplement, featuring a concise two-ingredient formula. This product achieved an N+ Score of 58, corresponding to an 'F' grade, which indicates a low overall quality rating. Notably, it provides Vitamin C at a clinical dose of 120 mg per tablet. However, the second component is a 210 mg 'Proprietary Blend,' which lacks specific ingredient transparency regarding individual dosages. The product's ingredient adequacy and formula completeness scores are both 50%, reflecting the limited number of ingredients and the proprietary blend. With 100% label transparency for the disclosed ingredients, this supplement is designed for individuals interested in a combination of Vitamin C and a botanical blend, though the N+ grade suggests a need for more detailed information on the proprietary components.

About This Product

Porphyra-Zyme by Biotics Research is a vitamins & minerals supplement containing 2 active ingredients. It has earned an N+ Score of 58/100 (Grade F).

Notable clinical-dose ingredients include Vitamin C.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity42/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • No major weaknesses identified

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Vitamin C120.000 mgAdequate
Proprietary Blend210.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.